Study Of Perennial Allergic Rhinitis
Phase 3
Completed
- Conditions
- Rhinitis, Allergic, Seasonal
- Registration Number
- NCT00358475
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Adverse events and laboratory blood test
- Secondary Outcome Measures
Name Time Method Change of nasal symptom score
Trial Locations
- Locations (1)
GSK Investigational Site